Schedule 13G ownership disclosure
Regulus Therapeutics Inc.
Security class unavailable · CUSIP: 75915K101
Event date: 2017-03-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 0
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-17-000520
- Form type
- SC 13G
- Filer
- Regulus Therapeutics Inc.
- CIK
- CIK 1505512
- Filed
- Apr 10, 2017
- Reporting period
- Mar 31, 2017
- Description
- Schedule 13G beneficial ownership